Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Lumera forms new bioscience subsidiary
August 2007
SHARING OPTIONS:

BOTHELL, Wash.—Nanotechnology company Lumera Corp. has formed a wholly owned subsidiary known as Plexera Bioscience LLC. The new subsidiary will serve as the operations unit of Lumera's bioscience business and will be led by Dr. Joseph Vallner as chairman and CEO and Dr. Tim Londergan as president and COO. Lumera has engaged Robert W. Baird & Co. to assist the company in evaluating partnering and financing alternatives over the coming months. In 2006, Lumera created a separate bioscience operating unit within the company—which Londergan managed—to facilitate its drive toward successful market commercialization and the transition from a research and development company. Plexera will remain focused on providing the life sciences market with tools, content, and methods to simplify and accelerate proteomic discovery for therapeutic antibodies as well as predictive biomarkers.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.